Page last updated: 2024-11-05

ticlopidine and Arterial Occlusive Diseases

ticlopidine has been researched along with Arterial Occlusive Diseases in 94 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research Excerpts

ExcerptRelevanceReference
"Ticlopidine is increasingly used in the secondary prophylaxis in patients with arterial occlusive diseases."7.70Ticlopidine induced prolonged leucopenia in a patient with immunocytoma and chronic hepatitis C. ( Ehringer, H; Minar, E; Parschalk, B; Redlich, K, 1999)
"Ferric chloride has been widely used to induce arterial thrombosis in a variety of species."5.33An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. ( Wang, X; Xu, L, 2005)
" Our case report suggests that antithrombotic treatment by targeting of the activated platelets with a potent platelet inhibitor during the acute phase of type II HIT syndrome followed by long-term administration of oral anticoagulation may be an additional, safe and effective therapeutic alternative that merits to be systematically studied."5.33Recurrent arterial thromboses in a woman with heparin induced thrombocytopenia, successfully managed with iloprost followed by clopidogrel. An alternative therapeutic option for heparin induced thrombocytopenia type II syndrome. ( Alexandridou, S; Betsis, D; Blouhos, K; Megalopoulos, A; Tsachalis, T; Tsalis, K; Vasiliadis, K, 2006)
"Clopidogrel reduces arterial thrombus cohesion by an effect that correlates with inhibition of ADP-induced platelet aggregation."5.32Reduced thrombus cohesion in an ex vivo human model of arterial thrombosis induced by clopidogrel treatment: kinetics of the effect and influence of single and double loading-dose regimens. ( Bal dit Sollier, C; Berge, N; Bergmann, JF; Drouet, L; Mahé, I; Simoneau, G, 2003)
"Thrombocytopenia is rapid in onset and antibody mediated."5.32Repetitive profound thrombocytopenia after treatment with tirofiban: a case report. ( Erkoc, R; Eryonucu, B; Tuncer, M, 2004)
"Accordingly, 50 mg clopidogrel plus aspirin, and 75 mg clopidogrel plus aspirin were all superior to aspirin alone as stroke prevention in patients with cerebral infarction or transient ischemic attack combined with intracranial and extracranial arteriostenosis."5.24The effectiveness and safety of dual antiplatelet therapy in ischemic cerebrovascular disease with intracranial and extracranial arteriostenosis in Chinese patients: A randomized and controlled trail. ( Dong, AQ; Liu, H; Liu, JQ; Su, N; Wu, HJ; Zuo, FT, 2017)
"To assess the clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole (MRD) alone or with aspirin (ASA) compared with ASA (and each other where appropriate) in the prevention of occlusive vascular events in patients with a history of MI, ischaemic stroke/TIA or established peripheral arterial disease."4.87Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis. ( Bagust, A; Blundell, M; Boland, A; Dickson, R; Dundar, Y; Fisher, M; Greenhalgh, J; Martin Saborido, C; Oyee, J; Proudlove, C, 2011)
" Among the key recommendations in this chapter are the following: For patients with chronic limb ischemia, we recommend lifelong aspirin therapy in comparison to no antiplatelet therapy in patients with clinically manifest coronary or cerebrovascular disease (Grade 1A) and in those without clinically manifest coronary or cerebrovascular disease (Grade 1C+)."4.82Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. ( Clagett, GP; Jackson, MR; Lip, GY; Sobel, M; Tangelder, M; Verhaeghe, R, 2004)
"Ticlopidine is increasingly used in the secondary prophylaxis in patients with arterial occlusive diseases."3.70Ticlopidine induced prolonged leucopenia in a patient with immunocytoma and chronic hepatitis C. ( Ehringer, H; Minar, E; Parschalk, B; Redlich, K, 1999)
"Ischemic event rates were estimated for 12,931 aspirin users drawn from the Saskatchewan Health population between 1990 and 1995 who had an index diagnosis of myocardial infarction, ischemic stroke, or peripheral arterial disease."3.70Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Clopidogrel versus Aspirin in Patients at Risk of Ischaemi ( Caro, JJ; Migliaccio-Walle, K, 1999)
"Combination antiplatelet agents, particularly aspirin and ticlopidine, have found increased use in the prevention of arterial thrombosis."3.70A pharmacodynamic study of clopidogrel in chronic hemodialysis patients. ( Fiore, L; Hasbargen, JA; Kaufman, JS; O'Connor, TZ; Perdriset, G, 2000)
"Sarpogrelate is a selective 5-hydroxytryptamine (5-HT) receptor subtype 2A antagonist which blocks 5-HT induced platelet aggregation and proliferation of vascular smooth muscle cells."2.80Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results. ( Chen, YX; Gu, YQ; Hu, HJ; Li, XQ; Liu, CW; Song, XJ; Tian, HY; Wang, WD; Zhao, JC, 2015)
"Aspirin has been shown to be effective in reducing the associated risk of myocardial infarction and stroke."2.40Management of peripheral arterial disease. ( Hilleman, DE, 1998)
"Arterial thrombosis was induced by insertion of a silk thread (thrombogenic substrate) into an extracorporeal shunt."1.36Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the rat. ( Calmettes, Y; Le Grand, B; Leparq-Panissié, A; Létienne, R; Nadal-Wollbold, F; Perez, M, 2010)
"Ferric chloride has been widely used to induce arterial thrombosis in a variety of species."1.33An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. ( Wang, X; Xu, L, 2005)
" Our case report suggests that antithrombotic treatment by targeting of the activated platelets with a potent platelet inhibitor during the acute phase of type II HIT syndrome followed by long-term administration of oral anticoagulation may be an additional, safe and effective therapeutic alternative that merits to be systematically studied."1.33Recurrent arterial thromboses in a woman with heparin induced thrombocytopenia, successfully managed with iloprost followed by clopidogrel. An alternative therapeutic option for heparin induced thrombocytopenia type II syndrome. ( Alexandridou, S; Betsis, D; Blouhos, K; Megalopoulos, A; Tsachalis, T; Tsalis, K; Vasiliadis, K, 2006)
"Although saddle embolism is a relatively rare event, orthopaedic surgeons should be aware of this condition."1.33Saddle embolism after corrective femoral osteotomy: a case report. ( Hoshino, Y; Kariya, Y; Konishi, H; Noguchi, K; Ohashi, Y; Sekiya, H, 2006)
"Clopidogrel reduces arterial thrombus cohesion by an effect that correlates with inhibition of ADP-induced platelet aggregation."1.32Reduced thrombus cohesion in an ex vivo human model of arterial thrombosis induced by clopidogrel treatment: kinetics of the effect and influence of single and double loading-dose regimens. ( Bal dit Sollier, C; Berge, N; Bergmann, JF; Drouet, L; Mahé, I; Simoneau, G, 2003)
"Most patients with PAD die of either heart attacks or strokes and they die of the former conditions far earlier than controls."1.32[Antiplatelet therapy in patients with peripheral arterial disease (PAD)]. ( Diehm, C; Huber, R; Lawall, H, 2004)
"No or only a mild restenosis developed in 27 patients."1.32Clinical and angiographic outcome after interventional treatment of the iliac arteries with a new carbofilm coated stent: preliminary results. ( Butz, B; Feuerbach, S; Lenhart, M; Link, J; Paetzel, C; Pfister, K; Schleicher, T; Stern, U, 2004)
"Thrombocytopenia is rapid in onset and antibody mediated."1.32Repetitive profound thrombocytopenia after treatment with tirofiban: a case report. ( Erkoc, R; Eryonucu, B; Tuncer, M, 2004)
"Ticlopidine was significantly effective only at 100 mg/kg p."1.28Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease. ( Hara, H; Kitajima, A; Shimada, H; Tamao, Y, 1991)

Research

Studies (94)

TimeframeStudies, this research(%)All Research%
pre-199011 (11.70)18.7374
1990's20 (21.28)18.2507
2000's44 (46.81)29.6817
2010's19 (20.21)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baudoin, Y1
Guilhem, K1
Meyrat, L1
Thouard, H1
Chen, YX1
Wang, WD1
Song, XJ1
Gu, YQ1
Tian, HY1
Hu, HJ1
Zhao, JC1
Li, XQ1
Liu, CW1
Huebert, I1
Heinicke, N1
Kook, D1
Boost, KA1
Miller, CV1
Mayer, WJ1
Haritoglou, C1
Kampik, A1
Gandorfer, A1
Hintschich, C1
Wolf, A1
Dake, MD1
Ansel, GM1
Jaff, MR1
Ohki, T1
Saxon, RR1
Smouse, HB1
Machan, LS1
Snyder, SA1
O'Leary, EE1
Ragheb, AO1
Zeller, T1
Hummel, T1
Meves, SH1
Rüdiger, K1
Mügge, A1
Mumme, A1
Burkert, B1
Mühlberger, D1
Neubauer, H1
Zuo, FT1
Liu, H1
Wu, HJ1
Su, N1
Liu, JQ1
Dong, AQ1
Raynaud, A1
Novelli, L1
Rovani, X1
Carreres, T1
Bourquelot, P1
Hermelin, A1
Angel, C1
Beyssen, B1
Tacke, J1
Lindhoff-Last, E4
Linnemann, B3
Schwonberg, J1
Rechner, AR1
Mani, H3
Létienne, R1
Leparq-Panissié, A1
Calmettes, Y1
Nadal-Wollbold, F1
Perez, M1
Le Grand, B1
Liu, L1
Zeng, F1
Zeng, X1
Xue, Q1
Nie, S1
Kang, C1
Wu, J1
Kang, Q1
Wang, X3
Liu, X1
Li, T1
Chen, J1
Li, Q1
Xu, R1
Yang, X1
Kang, H1
Jiang, F1
Li, Z1
Zhang, L1
Long, Y1
Mehmeti, N1
Budak, K1
Meier, T1
Schneider, JR1
Verta, MJ1
Alonzo, MJ1
Hahn, D1
Patel, NH1
Kim, S1
Greenhalgh, J1
Bagust, A1
Boland, A1
Martin Saborido, C1
Oyee, J1
Blundell, M1
Dundar, Y1
Dickson, R1
Proudlove, C1
Fisher, M1
Wiesemann, S1
Passlick, B1
Thalhammer, A1
Wolf, Z1
Tirneci, V1
Vogl, TJ1
Edelgard Lindhoff-Last, A1
Cooley, BC1
Meyer, S1
Liang, GZ1
Zhang, FX1
Luo, XY1
Zhang, CM1
Hu, L1
Feng, YP1
Niu, LY1
Zhang, H1
Ma, BB1
Qi, HS1
Guo, MM1
Long, YY1
Li, HL1
Avegliano, G1
Evangelista, A1
Elorz, C1
González-Alujas, T1
García del Castillo, H1
Soler-Soler, J1
Turpie, AG1
Hiller, E1
Pasqualini, L1
Pirro, M1
Lombardini, R1
Ciuffetti, G1
Dragani, P1
Mannarino, E1
Ziegler, S1
Maca, T1
Alt, E1
Speiser, W1
Schneider, B1
Minar, E2
Wohlgemuth, WA1
Bohndorf, K1
Dörffler-Melly, J1
Schmidli, J1
Mahler, F1
Strecker, EP1
Boos, IB1
Göttmann, D1
Vetter, S1
Yilmaz, S1
Sindel, T1
Yegin, A1
Lüleci, E1
Wilhite, DB1
Comerota, AJ1
Schmieder, FA1
Throm, RC1
Gaughan, JP1
Rao, AK1
Bal dit Sollier, C1
Mahé, I1
Berge, N1
Simoneau, G1
Bergmann, JF1
Drouet, L1
Aronow, WS1
Clagett, GP2
Sobel, M1
Jackson, MR2
Lip, GY1
Tangelder, M1
Verhaeghe, R2
Conforto, AB1
Puglia, P1
Yamamoto, FI1
Scaff, M1
Diehm, C1
Lawall, H1
Huber, R1
Füessl, HS1
Butz, B1
Paetzel, C1
Stern, U1
Schleicher, T1
Pfister, K1
Link, J1
Feuerbach, S1
Lenhart, M1
Xu, L1
Eryonucu, B1
Tuncer, M1
Erkoc, R1
Durand-Zaleski, I1
Bertrand, M2
Weintraub, W1
Jönsson, B1
Baumgartner, I1
Klinkhardt, U1
Harder, S1
Hoefer, IE1
Grundmann, S1
Schirmer, S1
van Royen, N1
Meder, B1
Bode, C1
Piek, JJ1
Buschmann, IR1
Tulsyan, N1
Ouriel, K1
Kashyap, VS1
Megalopoulos, A1
Vasiliadis, K1
Tsachalis, T1
Tsalis, K1
Blouhos, K1
Alexandridou, S1
Betsis, D1
Heiss, JM1
Kirichenko, AA1
Wong, S1
Morel-Kopp, MC1
Chen, Q1
Appleberg, M1
Ward, CM1
Lewis, DR1
Sekiya, H1
Noguchi, K1
Ohashi, Y1
Kariya, Y1
Hoshino, Y1
Konishi, H1
Luxembourg, B2
Kirchmayr, K1
Collins, P1
Ford, I1
Greaves, M1
Macaulay, E1
Brittenden, J1
Singer, E1
Imfeld, S1
Hoffmann, U1
Buschmann, I1
Labs, KH1
Jaeger, KA1
Toennes, SW1
Strubel, G1
Klaeffling, C1
Daemgen-von Brevern, G1
Geisen, C1
Mortensen, J1
Poulsen, TS1
Refsgaard, J1
Kristensen, SD1
Landolfi, R1
Di Gennaro, L1
Stiegler, H2
Hess, H1
Mietaschk, A1
Trampisch, HJ1
Ingrisch, H1
Katsumura, T2
Day, HJ1
Goebel, N1
Pfluger, N1
Speiser, K1
Turina, M1
Rothlin, M1
Mishima, Y1
Kamiya, K1
Sakaguchi, S1
Tanabe, T1
Sakuma, A1
Klingemann, HG1
Egbring, R1
Fitzgerald, GA1
Meagher, EA1
Shirakura, S1
Higo, K1
Takeda, M1
Karasawa, A1
van Gijn, J1
Algra, A1
Andreozzi, GM1
Signorelli, SS1
Cacciaguerra, G1
Di Pino, L1
Martini, R1
Monaco, S1
Buttò, G1
Sardina, M1
Castillo, V1
Bogousslavsky, J1
Vuadens, P1
Ishida, H2
Nakayasu, H2
Nukaya, H2
Tsuji, K2
Bertrand, ME1
Legrand, V1
Boland, J1
Fleck, E1
Bonnier, J1
Emmanuelson, H1
Vrolix, M1
Missault, L1
Chierchia, S1
Casaccia, M1
Niccoli, L1
Oto, A1
White, C1
Webb-Peploe, M1
Van Belle, E1
McFadden, EP1
Hilleman, DE1
Koskin, VM1
Bogdanets, LI1
Priollet, P1
Forbes, CD1
Lowe, GD1
MacLaren, M1
Shaw, BG1
Dickinson, JP1
Kieffer, G1
Redlich, K1
Parschalk, B1
Ehringer, H1
Caro, JJ1
Migliaccio-Walle, K1
Kaufman, JS1
Fiore, L1
Hasbargen, JA1
O'Connor, TZ1
Perdriset, G1
Gusak, VK1
Shtutin, AA1
Rodin, IuV1
Il'iushchenko, SV1
Iurchuk, AIu1
Haldemann, R1
Lüscher, TF1
Szucs, TD1
Sugio, Y1
Okamura, T1
Shimoda, K1
Matsumoto, M1
Yagi, H1
Ishizashi, H1
Niho, Y1
Inaba, S1
Fujimura, Y1
Bartorelli, AL1
Trabattoni, D1
Montorsi, P1
Fabbiocchi, F1
Galli, S1
Ravagnani, P1
Grancini, L1
Cozzi, S1
Loaldi, A1
Blanchard, JF1
Carreras, LO1
Coccheri, S1
Palareti, G1
Fortunato, G1
Hara, H1
Shimada, H1
Kitajima, A1
Tamao, Y1
Arcan, JC1
Panak, E1
Gemelli, A1
Leone, G1
Berni, A1
Pacelli, M1
Harker, LA1
Arpaia, MR1
Leonardo, G1
del Guercio, R1
Di Perri, T1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Multicenter, Randomized, Controlled, Superiority Clinical Trial to Evaluate the Safety and Efficacy of Drug-eluting Peripheral Arterial Stent System(G-stream) in the Treatment of the Above-the-knee Femoropopliteal Artery Stenosis or Occlusion[NCT05780359]280 participants (Anticipated)Interventional2022-05-27Recruiting
Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery[NCT00120406]474 participants (Actual)Interventional2005-03-31Completed
A Post-Market, Prospective, Multi-Center, Study to Evaluate Safety and Efficacy of the StarClose™ Vascular Closure System in Patients Who Are Ambulated Early Post-Diagnostic Catheterization[NCT00736086]165 participants (Actual)Observational2006-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Event-free Survival Rate

"Event-free survival is defined as freedom from the major adverse events of death, target lesion revascularization, target limb ischemia requiring surgical intervention (bypass or amputation of toe, foot or leg), surgical repair of the target vessel (e.g., dissection requiring surgery), and from worsening of the Rutherford classification by 2 classes or to class 5 or 6.~Participant flow is based on initial randomization of Zilver PTX or PTA (Percutaneous balloon angioplasty), and Event-free survival is based on Per-Protocol analysis where only patients who were treated according to their initial randomization are counted." (NCT00120406)
Timeframe: 12 months

InterventionPercentage of participants (Number)
Zilver PTX90.4
PTA (Control)83.9

Primary Patency

Primary patency is defined as a Peak systolic velocity (PSV) ratio < 2.0 or angiographic percent diameter stenosis < 50%. (NCT00120406)
Timeframe: 12 months

InterventionPercentage of participants (Number)
Zilver PTX82.7
PTA (Control)32.7

Reviews

19 reviews available for ticlopidine and Arterial Occlusive Diseases

ArticleYear
[Medicinal therapy for interventional surgery of the peripheral vascular system].
    Der Radiologe, 2010, Volume: 50, Issue:1

    Topics: Administration, Oral; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Therap

2010
Revaluation of clopidogrel: let the data speak for themselves.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2010, Volume: 30, Issue:3

    Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Cost-Benefit Analysis; Drug Therapy, Combination;

2010
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
    Health technology assessment (Winchester, England), 2011, Volume: 15, Issue:31

    Topics: Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Clopidogrel; Cost-Benefit Analysis; Delayed-Ac

2011
State of the art--a journey through the world of antithrombotic therapy.
    Seminars in thrombosis and hemostasis, 2002, Volume: 28 Suppl 3

    Topics: Ambulatory Care; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Coronary Disease; Fibrinolytic A

2002
[Endovascular brachytherapy to prevent restenosis after angioplasty].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2003, Volume: 175, Issue:2

    Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Brachyth

2003
Antiplatelet therapy in peripheral arterial disease.
    Current drug targets. Cardiovascular & haematological disorders, 2004, Volume: 4, Issue:3

    Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Humans; Peripheral Vascular Disease

2004
Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Chest, 2004, Volume: 126, Issue:3 Suppl

    Topics: Arterial Occlusive Diseases; Aspirin; Cilostazol; Clopidogrel; Contraindications; Evidence-Based Med

2004
The value of clopidogrel versus aspirin in reducing atherothrombotic events: the CAPRIE study.
    PharmacoEconomics, 2004, Volume: 22 Suppl 4

    Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Cost-Benefit Analysis; Humans; Multicenter Studie

2004
The value of clopidogrel in addition to standard therapy in reducing atherothrombotic events.
    PharmacoEconomics, 2004, Volume: 22 Suppl 4

    Topics: Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Benchmarking; Clopidogrel; Dru

2004
Emerging drugs in peripheral arterial disease.
    Expert opinion on emerging drugs, 2006, Volume: 11, Issue:1

    Topics: Administration, Oral; Anticoagulants; Arterial Occlusive Diseases; Arteries; Aspirin; Clopidogrel; D

2006
[Mechanism of action and clinical use of ticlopidine].
    Kardiologiia, 2006, Volume: 46, Issue:4

    Topics: Arterial Occlusive Diseases; Brain Ischemia; Diabetic Angiopathies; Fibrinolytic Agents; Humans; Myo

2006
Overview: clinical experiences with ticlopidine.
    Agents and actions. Supplements, 1984, Volume: 15

    Topics: Anemia, Sickle Cell; Anticoagulants; Arterial Occlusive Diseases; Cerebrovascular Disorders; Clinica

1984
Antiplatelet drugs.
    European journal of clinical investigation, 1994, Volume: 24 Suppl 1

    Topics: Animals; Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Integrins; Platelet Aggregation

1994
[Preventive treatment of cerebrovascular accidents of arterial origin].
    Praxis, 1996, Feb-06, Volume: 85, Issue:6

    Topics: Adult; Aged; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clinical Trials

1996
Management of peripheral arterial disease.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Oct-01, Volume: 55, Issue:19 Suppl 1

    Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Ticlopid

1998
[Ticlid: clinical effectiveness and significance in combined conservative treatment of chronic obliterating diseases of lower limb arteries].
    Terapevticheskii arkhiv, 1998, Volume: 70, Issue:9

    Topics: Arterial Occlusive Diseases; Chronic Disease; Humans; Leg; Platelet Aggregation Inhibitors; Safety;

1998
Antithrombotic therapy in peripheral arterial occlusive disease.
    Chest, 1998, Volume: 114, Issue:5 Suppl

    Topics: Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Endarterectomy, C

1998
[Arteriopathy of the lower limbs: toward a global medical care].
    La Revue de medecine interne, 1999, Volume: 20, Issue:6

    Topics: Angiography; Arterial Occlusive Diseases; Arteriosclerosis; Cilostazol; Clinical Trials as Topic; Cl

1999
Antiplatelet drugs in the management of patients with thrombotic disorders.
    Seminars in thrombosis and hemostasis, 1986, Volume: 12, Issue:2

    Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets

1986

Trials

21 trials available for ticlopidine and Arterial Occlusive Diseases

ArticleYear
Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results.
    Chinese medical journal, 2015, Jun-20, Volume: 128, Issue:12

    Topics: Aged; Arterial Occlusive Diseases; Clopidogrel; Female; Fibrinolytic Agents; Humans; Kaplan-Meier Es

2015
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
    Circulation, 2016, Apr-12, Volume: 133, Issue:15

    Topics: Adult; Aged; Angioplasty; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Combine

2016
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
    Circulation, 2016, Apr-12, Volume: 133, Issue:15

    Topics: Adult; Aged; Angioplasty; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Combine

2016
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
    Circulation, 2016, Apr-12, Volume: 133, Issue:15

    Topics: Adult; Aged; Angioplasty; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Combine

2016
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.
    Circulation, 2016, Apr-12, Volume: 133, Issue:15

    Topics: Adult; Aged; Angioplasty; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Combine

2016
[Prevalence of acetylsalicylic acid (ASA) - low response in vascular surgery].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2016, Volume: 87, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Stenosi

2016
The effectiveness and safety of dual antiplatelet therapy in ischemic cerebrovascular disease with intracranial and extracranial arteriostenosis in Chinese patients: A randomized and controlled trail.
    Medicine, 2017, Volume: 96, Issue:1

    Topics: Arterial Occlusive Diseases; Aspirin; China; Clopidogrel; Dose-Response Relationship, Drug; Drug The

2017
Assessment of clopidogrel non-response by the PFA-100 system using the new test cartridge INNOVANCE PFA P2Y.
    Annals of hematology, 2010, Volume: 89, Issue:6

    Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Catheterization, Per

2010
[A prospective randomized control clinical trial about clopidogrel combined with warfarin versus clopidogrel alone in the prevention of restenosis after femoral-popliteal artery angioplasty].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2012, Volume: 50, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Arterial Occlusive Diseases; Clopidogrel; Fema

2012
A human model of platelet-leucocyte adhesive interactions during controlled ischaemia in patients with peripheral vascular disease.
    Journal of clinical pathology, 2002, Volume: 55, Issue:12

    Topics: Adult; Arterial Occlusive Diseases; Blood Platelets; Blood Viscosity; Cell Adhesion; Clopidogrel; Do

2002
Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time.
    Journal of vascular surgery, 2003, Volume: 38, Issue:4

    Topics: Aged; Arterial Occlusive Diseases; Aspirin; Bleeding Time; Cilostazol; Clopidogrel; Drug Therapy, Co

2003
Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Thrombosis and haemostasis, 2006, Volume: 95, Issue:6

    Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Cardiovascular Disea

2006
Aspirin in peripheral arterial disease: breakthrough or pitfall?
    VASA. Zeitschrift fur Gefasskrankheiten, 2006, Volume: 35, Issue:3

    Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Collateral Circulation; Combined Modality Therapy

2006
[Effect of ticlopidine on peripheral obliterating arteriopathy].
    Deutsche medizinische Wochenschrift (1946), 1984, Aug-17, Volume: 109, Issue:33

    Topics: Angiography; Anticoagulants; Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Blind Met

1984
Therapeutic effect of ticlopidine for ischemic leg ulcers.
    Agents and actions. Supplements, 1984, Volume: 15

    Topics: Anticoagulants; Arterial Occlusive Diseases; Clinical Trials as Topic; Female; Humans; Ischemia; Leg

1984
Overview: clinical experiences with ticlopidine.
    Agents and actions. Supplements, 1984, Volume: 15

    Topics: Anemia, Sickle Cell; Anticoagulants; Arterial Occlusive Diseases; Cerebrovascular Disorders; Clinica

1984
Therapeutic effect of ticlopidine, a new inhibitor of platelet aggregation, on chronic arterial occlusive diseases, a double-blind study versus placebo.
    Angiology, 1982, Volume: 33, Issue:6

    Topics: Arterial Occlusive Diseases; Arteriosclerosis; Chronic Disease; Clinical Trials as Topic; Double-Bli

1982
Three-month therapy with calcium-heparin in comparison with ticlopidine in patients with peripheral arterial occlusive disease at Leriche-Fontaine IIb class.
    Angiology, 1993, Volume: 44, Issue:4

    Topics: Arterial Occlusive Diseases; Blood Gas Monitoring, Transcutaneous; Exercise Test; Female; Fibrinolyt

1993
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study.
    Circulation, 1998, Oct-20, Volume: 98, Issue:16

    Topics: Administration, Oral; Aged; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Coronary Disease;

1998
Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a beta-blocker and a calcium uptake antagonist.
    Seminars in thrombosis and hemostasis, 1999, Volume: 25 Suppl 2

    Topics: Adrenergic beta-Antagonists; Adult; Arterial Occlusive Diseases; Atenolol; Calcium Channel Blockers;

1999
[Application of preparation endotelon in complex treatment of chronic arterial insufficiency of lower extremities].
    Klinichna khirurhiia, 2000, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arterial Occlusive Diseases; Aspirin; Biflavo

2000
Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2002, Volume: 55, Issue:2

    Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis Implantation; Carbon; Coa

2002
A double-blind, placebo-controlled multicentre trial of ticlopidine in patients with peripheral arterial disease in Argentina. Design, organization and general characteristics of patients at entry. The EMATAP Group.
    Nouvelle revue francaise d'hematologie, 1992, Volume: 34, Issue:2

    Topics: Adult; Aged; Argentina; Arterial Occlusive Diseases; Double-Blind Method; Female; Follow-Up Studies;

1992
Ticlopidine in the treatment of peripheral occlusive arterial disease.
    Seminars in thrombosis and hemostasis, 1989, Volume: 15, Issue:2

    Topics: Arterial Occlusive Diseases; Blood Flow Velocity; Clinical Trials as Topic; Exercise Test; Humans; I

1989

Other Studies

55 other studies available for ticlopidine and Arterial Occlusive Diseases

ArticleYear
Images of an occlusive arterial disease of lower extremity due to chronic intoxication by ergot alkaloid.
    Journal of vascular surgery, 2014, Volume: 60, Issue:3

    Topics: Arterial Occlusive Diseases; Clopidogrel; Drug Substitution; Female; Humans; Lower Extremity; Methys

2014
Dual platelet inhibition in cases of severe retrobulbar hemorrhage following retrobulbar and peribulbar anesthesia.
    Journal of cataract and refractive surgery, 2015, Volume: 41, Issue:10

    Topics: Aged; Anesthesia, Local; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cardiac Surgical Proc

2015
Radiocephalic fistula complicated by distal ischemia: treatment by ulnar artery dilatation.
    Cardiovascular and interventional radiology, 2010, Volume: 33, Issue:1

    Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Catheters, Indwelling; Clopidogrel; Diabete

2010
Antithrombotic activity of F 16618, a new PAR1 antagonist evaluated in extracorporeal arterio-venous shunt in the rat.
    Biochemical pharmacology, 2010, Jun-01, Volume: 79, Issue:11

    Topics: Animals; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical; Aspirin; Bleeding Time; Clopido

2010
[Diagnosis of peripheral arterial occlusive disease].
    Praxis, 2010, Sep-08, Volume: 99, Issue:18

    Topics: Algorithms; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Blood Pressure Determination

2010
Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease.
    Vascular and endovascular surgery, 2011, Volume: 45, Issue:5

    Topics: Aged; Aged, 80 and over; Amputation, Surgical; Ankle Brachial Index; Anticoagulants; Arterial Occlus

2011
[Perioperative management of antiplatelet therapy in thoracic surgery. A survey of German hospitals].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2012, Volume: 83, Issue:6

    Topics: Arterial Occlusive Diseases; Aspirin; Attitude of Health Personnel; Brain Ischemia; Clopidogrel; Com

2012
Late peripheral stent thrombosis due to stent fracture, vigorous exercise and hyporesponsiveness to clopidogrel.
    VASA. Zeitschrift fur Gefasskrankheiten, 2012, Volume: 41, Issue:2

    Topics: Aged; Angioplasty; Arterial Occlusive Diseases; Bicycling; Clopidogrel; Constriction, Pathologic; Dr

2012
Collagen-induced thrombosis in murine arteries and veins.
    Thrombosis research, 2013, Volume: 131, Issue:1

    Topics: Animals; Arterial Occlusive Diseases; Blood Coagulation; Blood Platelets; Carotid Arteries; Clopidog

2013
[Platelet inhibition in clinical practice].
    Therapeutische Umschau. Revue therapeutique, 2012, Volume: 69, Issue:11

    Topics: Aged; Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Clo

2012
Acute peripheral arterial ischemia and suspected aortic dissection: usefulness of transesophageal echocardiography in differential diagnosis with aortic thrombosis.
    The American journal of cardiology, 2002, Sep-15, Volume: 90, Issue:6

    Topics: Acute Disease; Adult; Aged; Amputation, Surgical; Anticoagulants; Aortic Diseases; Arterial Occlusiv

2002
[Long-term anticoagulation after bypass operation].
    Der Internist, 2002, Volume: 43, Issue:8

    Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Humans; Long-Term Care; Platelet Aggregation Inhi

2002
Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients.
    Platelets, 2002, Volume: 13, Issue:8

    Topics: Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Blood Platelets;

2002
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
    Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:1

    Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Bl

2003
Clopidogrel plus long-term aspirin after femoro-popliteal stenting. The CLAFS project: 1- and 2-year results.
    European radiology, 2004, Volume: 14, Issue:2

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon; Anticoagula

2004
Subintimal angioplasty of long superficial femoral artery occlusions.
    Journal of vascular and interventional radiology : JVIR, 2003, Volume: 14, Issue:8

    Topics: Angioplasty; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Female; Femoral Artery; Fibrinolytic

2003
Reduced thrombus cohesion in an ex vivo human model of arterial thrombosis induced by clopidogrel treatment: kinetics of the effect and influence of single and double loading-dose regimens.
    Thrombosis research, 2003, Volume: 111, Issue:1-2

    Topics: Adult; Arterial Occlusive Diseases; Clopidogrel; Confidence Intervals; Drug Administration Schedule;

2003
[Even when walking yet does not cause any pain, peripheral arterial occlusive disease costs life years].
    MMW Fortschritte der Medizin, 2003, Apr-10, Volume: 145, Issue:15

    Topics: Arterial Occlusive Diseases; Clinical Trials as Topic; Clopidogrel; Diabetes Complications; Humans;

2003
Progressive cervicocranial arteriopathy with dilatations and stenoses: case report.
    Arquivos de neuro-psiquiatria, 2004, Volume: 62, Issue:3B

    Topics: Adult; Arterial Occlusive Diseases; Aspirin; Basilar Artery; Carotid Artery Diseases; Carotid Artery

2004
[Antiplatelet therapy in patients with peripheral arterial disease (PAD)].
    Medizinische Klinik (Munich, Germany : 1983), 2004, Aug-15, Volume: 99 Suppl 1

    Topics: Arterial Occlusive Diseases; Aspirin; Cause of Death; Cerebral Infarction; Clopidogrel; Coronary Art

2004
[Acute coronary syndrome, stroke, arterial occlusive disease. Bring the patients out of the danger zone!].
    MMW Fortschritte der Medizin, 2004, Volume: 146 Suppl 1

    Topics: Arterial Occlusive Diseases; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Emboli

2004
[Attack on many vascular fronts. Atherothrombosis trouble seldom comes alone].
    MMW Fortschritte der Medizin, 2004, Volume: 146 Suppl 1

    Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel;

2004
[Patients with arterial occlusive disease die of myocardial infarct or stroke. The dangerous sisters: arterial occlusive disease and coronary heart disease].
    MMW Fortschritte der Medizin, 2004, Volume: 146 Suppl 1

    Topics: Aged; Arterial Occlusive Diseases; Aspirin; Cause of Death; Clinical Trials as Topic; Clopidogrel; C

2004
Clinical and angiographic outcome after interventional treatment of the iliac arteries with a new carbofilm coated stent: preliminary results.
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2004, Volume: 176, Issue:11

    Topics: Administration, Oral; Aged; Aged, 80 and over; Angiography; Anticoagulants; Arterial Occlusive Disea

2004
An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research.
    Thrombosis research, 2005, Volume: 115, Issue:1-2

    Topics: Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Chlorides; Clopidogrel; Disease Model

2005
Repetitive profound thrombocytopenia after treatment with tirofiban: a case report.
    Cardiovascular drugs and therapy, 2004, Volume: 18, Issue:6

    Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Administration Schedul

2004
[In diabetes and peripheral arterial occlusive disease: long-term treatment with clopidogrel].
    Praxis, 2005, May-11, Volume: 94, Issue:19

    Topics: Arterial Occlusive Diseases; Clinical Trials as Topic; Clopidogrel; Diabetic Angiopathies; Humans; L

2005
Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function?
    Seminars in thrombosis and hemostasis, 2005, Volume: 31, Issue:4

    Topics: Adenosine Diphosphate; Adult; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Clopidogrel; Fl

2005
Aspirin, but not clopidogrel, reduces collateral conductance in a rabbit model of femoral artery occlusion.
    Journal of the American College of Cardiology, 2005, Sep-20, Volume: 46, Issue:6

    Topics: Animals; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Disease Models, Animal; Electrophysiolog

2005
Recurrent arterial thromboses in a woman with heparin induced thrombocytopenia, successfully managed with iloprost followed by clopidogrel. An alternative therapeutic option for heparin induced thrombocytopenia type II syndrome.
    International angiology : a journal of the International Union of Angiology, 2006, Volume: 25, Issue:1

    Topics: Aged; Arterial Occlusive Diseases; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agen

2006
[Emergency measures in acute arterial occlusion. Why there are still colleagues who do it incorrectly?].
    MMW Fortschritte der Medizin, 2006, Mar-23, Volume: 148, Issue:12

    Topics: Acute Disease; Angiography; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Embolism; Emergencies

2006
Saddle embolism after corrective femoral osteotomy: a case report.
    Journal of orthopaedic surgery (Hong Kong), 2006, Volume: 14, Issue:2

    Topics: Arterial Occlusive Diseases; Atrial Fibrillation; Echocardiography, Transesophageal; Embolectomy; Em

2006
Response to aspirin and clopidogrel monitored with different platelet function methods.
    Platelets, 2006, Volume: 17, Issue:5

    Topics: Aged; Arterial Occlusive Diseases; Aspirin; Automation; Blood Platelets; Clopidogrel; Female; Humans

2006
Surgical revascularisation in patients with severe limb ischaemia induces a pro-thrombotic state.
    Platelets, 2006, Volume: 17, Issue:5

    Topics: Aged; Aged, 80 and over; Antithrombin III; Arterial Occlusive Diseases; Aspirin; Blood Coagulation;

2006
Factitious anticoagulant-resistance as a cause of recurrent arterial bypass graft occlusions.
    Thrombosis and haemostasis, 2007, Volume: 97, Issue:6

    Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Clopidogrel; Drug Resistance; Drug Therapy, Co

2007
Do the Behring Coagulation Timer and the Platelet Function Analyzer-100 identify the same patients as being aspirin non-responders?
    Platelets, 2007, Volume: 18, Issue:5

    Topics: Aged; Arterial Occlusive Diseases; Aspirin; Automation; Blood Platelets; Clopidogrel; Female; Humans

2007
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
    Haematologica, 2008, Volume: 93, Issue:3

    Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans;

2008
[Changes in the unmodified vessels after aortocoronary bypass surgery].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1983, Volume: 139, Issue:6

    Topics: Angina Pectoris; Anticoagulants; Arterial Occlusive Diseases; Coronary Artery Bypass; Coronary Disea

1983
[Platelet release proteins in plasma in peripheral arterial obliterative disease during ticlopidine administration].
    Deutsche medizinische Wochenschrift (1946), 1982, Sep-17, Volume: 107, Issue:37

    Topics: Adult; Arterial Occlusive Diseases; Blood Coagulation Factors; Double-Blind Method; Female; Humans;

1982
Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs.
    Japanese journal of pharmacology, 1994, Volume: 65, Issue:2

    Topics: Animals; Arterial Occlusive Diseases; Aspirin; Benzimidazoles; Benzoxepins; Blood Coagulation; Blood

1994
Ticlopidine, trials, and torture.
    Stroke, 1994, Volume: 25, Issue:6

    Topics: Arterial Occlusive Diseases; Aspirin; Cause of Death; Cerebrovascular Disorders; Clinical Trials as

1994
[Oral anticoagulation in activated protein C resistance?].
    Deutsche medizinische Wochenschrift (1946), 1996, Dec-20, Volume: 121, Issue:51-52

    Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Drug Resistance; Humans; Male; Middle Aged; Ph

1996
Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. II. Prophylactic effect of scymnol on lesion development in a rat peripheral arterial occlusion model.
    Biological & pharmaceutical bulletin, 1998, Volume: 21, Issue:3

    Topics: Animals; Antithrombins; Arginine; Arterial Occlusive Diseases; Blood Coagulation; Cholestanols; Elas

1998
Study of the pharmacological effect of the bile salt, sodium scymnol sulfate, from Rhizoprionodon acutus. III. Protective effect of scymnol against vascular endothelial cell damage in a rat peripheral arterial occlusion model.
    Biological & pharmaceutical bulletin, 1999, Volume: 22, Issue:8

    Topics: Alanine Transaminase; Animals; Antithrombin III; Arginine; Arterial Occlusive Diseases; Aspartate Am

1999
Ticlopidine induced prolonged leucopenia in a patient with immunocytoma and chronic hepatitis C.
    VASA. Zeitschrift fur Gefasskrankheiten, 1999, Volume: 28, Issue:4

    Topics: Aged; Arterial Occlusive Diseases; Bone Marrow; Female; Hepatitis C, Chronic; Humans; Leukemia, Lymp

1999
Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. CAPRA (CAPRIE Actual Practice Rates Analysis) Study Group. Clopidogrel versus Aspirin in Patients at Risk of Ischaemi
    The American journal of medicine, 1999, Volume: 107, Issue:6

    Topics: Aged; Arterial Occlusive Diseases; Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; C

1999
A pharmacodynamic study of clopidogrel in chronic hemodialysis patients.
    Journal of thrombosis and thrombolysis, 2000, Volume: 10, Issue:2

    Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Chronic Disease; Clopidogrel; Dose-Response Rela

2000
[Cost effectiveness of clopidogrel in secondary cardiovascular prevention: a cost-effectiveness analysis based on the Caprie Study].
    Praxis, 2001, Mar-29, Volume: 90, Issue:13

    Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Cerebral Hemorrhage; Cerebral Infarction; Clopido

2001
Ticlopidine-Associated thrombotic thrombocytopenic purpura with an IgG-type inhibitor to von Willebrand factor-cleaving protease activity.
    International journal of hematology, 2001, Volume: 74, Issue:3

    Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Arterial Occlusive Diseases; Autoantibodies; Humans; Immunog

2001
Ticlopidine.
    Lancet (London, England), 1991, Jun-22, Volume: 337, Issue:8756

    Topics: Arterial Occlusive Diseases; Humans; Ticlopidine

1991
Prophylactic antiplatelet therapy in peripheral arterial disease.
    Drugs, 1991, Volume: 42 Suppl 5

    Topics: Arterial Occlusive Diseases; Arteries; Humans; Leg; Peripheral Vascular Diseases; Platelet Aggregati

1991
Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease.
    Arzneimittel-Forschung, 1991, Volume: 41, Issue:6

    Topics: Animals; Arterial Occlusive Diseases; Carrageenan; Fibrinolytic Agents; Infarction; Lauric Acids; Ma

1991
[Use of ticlopidine in a group of patients with obliterative arteriopathy of the lower extremities].
    La Clinica terapeutica, 1987, Jul-31, Volume: 122, Issue:2

    Topics: Arterial Occlusive Diseases; Drug Evaluation; Gait; Humans; Leg; Ticlopidine; Time Factors

1987
[Control of platelet antiaggregation therapy using an electronic aggregometer on whole blood].
    Minerva cardioangiologica, 1986, Volume: 34, Issue:4

    Topics: Aged; Arterial Occlusive Diseases; Equipment and Supplies; Evaluation Studies as Topic; Female; Huma

1986
[Prevention and medical treatment of polyregional vascular lesions].
    Cardiologia (Rome, Italy), 1985, Volume: 30, Issue:11

    Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Diet; Dipyridamole; D

1985